ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Anthony C. Ralph-Edwards
Christopher M. Feindel
Michael F.X. Glynn
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ralph-Edwards, A. C.
Right arrow Articles by Glynn, M. F. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ralph-Edwards, A. C.
Right arrow Articles by Glynn, M. F. X.

Ann Thorac Surg 1994;57:1326-1328
© 1994 The Society of Thoracic Surgeons

Articles

Successful treatment of massive pulmonary embolism after coronary artery bypass grafting due to heparin-induced thrombocytopenia

Anthony C. Ralph-Edwards, MD, Christopher M. Feindel, MD*, Michael F.X. Glynn, MD

Departments of Cardiovascular Surgery and Hematology, University of Toronto, Toronto Hospital, General Division, Toronto, Ontario, Canada

Accepted for publication August 13, 1993.

* Address reprint requests to Dr Feindel, Division of Cardiovascular Surgery, The Toronto Hospital, 200 Elizabeth St, 14 Eaton N-222, Toronto, Ont, M5G 2C4, Canada.

Massive pulmonary embolism is a rare complication in patients undergoing coronary artery bypass grafting. Frequently patients have had exposure to heparin before the operation. In this article we report a patient who 6 days after a cardiac operation suffered a massive pulmonary embolism. The patient was later discovered to have heparin-associated thrombocytopenia with serum heparin antibody. We recommend patients receiving heparin have frequent platelet counts and those with induced thrombocytopenia undergo sensitivity testing.




This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
E. E. Gul, T. Abdulhalikov, R. Aslan, and I. Aydogdu
A Rare and Undesirable Complication of Heparin-Induced Thrombocytopenia: Acute Massive Pulmonary Embolism
Clinical and Applied Thrombosis/Hemostasis, October 1, 2011; 17(5): 546 - 548.
[Abstract] [PDF]

Home page
 Interact CardioVasc Thorac SurgHome page
U. Dandekar, J. Young, M. Kalkat, and C. M. R. Satur
Heparin induced thrombocytopenia type II complicating coronary artery bypass surgery: a tale of caution
Interact CardioVasc Thorac Surg, March 1, 2004; 3(1): 121 - 123.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
S. Beholz, H. Grubitzsch, B. Bergmann, H.-G. Wollert, and L. Eckel
Anticoagulation in extracorporeal circulation using recombinant hirudin: a case report
Perfusion, May 1, 2000; 15(3): 257 - 260.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.